Previous research results suggested that MIR2052HG was related to estrogen receptor (ER)-positive breast cancer [28], which can be treated with aromatase inhibitors (AIs) by inhibiting the synthesis of estrogen [29]. Here, ESR1 is linked to breast carcinoma.